CXCL5 and colorectal carcinoma: CRC-derived exosomal HSPC111 can promote the activation of HSCs, thus leading to the upregulation of CXCL5, which targets CXCR2 expressed on CRC cells, increases the release of exosomal HSPC111 from CRC cells and promotes CRLM [237].